At a glance

What it is

What bupropion is, and what it is approved for

Bupropion increases norepinephrine and dopamine signaling in the brain. That is why it is often described as activating, and why it is less likely than many antidepressants to cause sexual side effects or sleepiness. It is sold as Wellbutrin SR and XL and as generics.

Wellbutrin XL is indicated for major depressive disorder and for preventing seasonal affective disorder. The SR label states that Wellbutrin SR itself is not approved for smoking cessation but contains the same ingredient as the smoking-cessation product Zyban. Weight loss is not an approved use of bupropion by itself.

Bupropion is also one of the two ingredients in Contrave. The other is naltrexone. That combination is the approved route for weight. See naltrexone and Contrave for the combination’s trials.

Who it is for

Who it is for, and who should avoid it

The clearest fit is a person with depression, especially when low energy, weight gain or sexual side effects have been a problem on other antidepressants. It is also an option for people trying to quit smoking. A physician may talk about it in a weight plan only when it fits for one of those reasons.

Heavy drinking, a head injury, a brain tumor and several other conditions raise seizure risk further, and other medicines can too. A physician should know every prescription and supplement you take.

How it is taken

Dosing and why it starts low

For depression, the Wellbutrin XL label starts at 150 mg once daily, with a usual target of 300 mg once daily after about four days. The SR label starts at 150 mg a day, can go to 300 mg a day after three days, and sets a maximum of 400 mg a day. Both labels say to raise the dose gradually, because seizure risk grows with dose. Reduced doses apply in liver impairment.

Contrave delivers 360 mg a day of bupropion. Anyone taking Contrave should not also take Wellbutrin, Zyban or any other bupropion product.

Bupropion for weight alone has no labeled dose. If a physician ever uses it that way, that is off-label judgment, and the seizure limits above still apply.

The evidence

What the evidence shows for weight

Bupropion is known to be mildly weight-neutral or weight-lowering compared with many antidepressants. Summit’s reference review of obesity guidelines found that bupropion alone is not mentioned in the major obesity guidelines, and that pooled trials put its weight effect at roughly 3 to 4 kg over 8 to 52 weeks compared with placebo. I list those figures as a reference summary, not as a result you should expect.

The approved weight product is the combination with naltrexone. In the 1,742-person COR-I trial, the combination lowered body weight 6.1 percent versus 1.3 percent on placebo over 56 weeks, and about 48 percent of people on the full dose lost at least 5 percent of body weight versus 16 percent on placebo. Whether bupropion alone would have matched part of that was not the question the trial asked.

People often assume a mood medicine helps weight only through mood. Bupropion’s effect on appetite and reward is real but modest. It is not a substitute for a GLP-1, and trials in different populations are not directly comparable.

Safety

Warnings, side effects and monitoring

• Seizures. This is the central risk and it is dose related. Never double up on missed doses, and never crush or chew SR or XL tablets.
• Smoking cessation. The label describes serious neuropsychiatric events reported in people taking bupropion to quit smoking, including mood change, hallucinations, aggression and suicidal thoughts. Stop it and call a physician if these appear.
• Common effects. Dry mouth, insomnia, headache, nausea, tremor and anxiety are typical. Raised blood pressure can occur and should be checked.
• Eyes. The pupil dilation can trigger angle-closure glaucoma in people with narrow angles.
• Alcohol. Reduced alcohol tolerance and neuropsychiatric events have been reported. Avoid heavy drinking and do not stop drinking suddenly after heavy use without medical advice.
• Urine drug screens. Bupropion can cause a false-positive amphetamine screen.

Monitoring is practical: blood pressure and mood checks, a full list of your medicines, and a review of any history of seizures, eating disorders or heavy alcohol use before the first dose.

If you stop

What happens if you stop

Bupropion is not known for severe withdrawal, but stopping an antidepressant should still be planned with the prescriber, since depression can return. If you take it for smoking cessation, the plan is usually a fixed course. If you take it as part of Contrave, stopping the combination ends its effect on appetite, and weight tends to come back as it does after most weight medicines. After stopping a GLP-1, weight returned in a trial extension, and bupropion has not been shown to prevent that. See what happens when you stop tirzepatide.

Summit’s role

Summit’s role with bupropion

Bupropion is not among the medicines Summit’s programs are built around, and I cannot confirm from Summit’s documents that Summit prescribes it. Summit does not dispense brand-name Contrave or Wellbutrin. Dr. Miranda reviews the medicines you already take and decides whether any add-on fits you after your history and labs. If your own doctor prescribes bupropion for depression or smoking, keep taking it as directed and tell us about it.

That matters because bupropion changes what else is safe. For example, it cannot be combined with another bupropion product, and seizure history changes the answer to many questions. A physician sees the whole list first.

Keep reading

Related medications

Sources

Where this comes from

All retrieved November 10, 2026.

1. Wellbutrin XL (bupropion hydrochloride extended-release tablets), prescribing information. DailyMed, U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a435da9d-f6e8-4ddc-897d-8cd2bf777b21
2. Wellbutrin SR (bupropion hydrochloride sustained-release tablets), prescribing information. DailyMed, U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cbc8c074-f080-4489-a5ae-207b5fadeba3
3. Contrave (naltrexone HCl and bupropion HCl) extended-release tablets, prescribing information. DailyMed, U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=485ff360-32c8-11df-928b-0002a5d5c51b
4. Greenway FL et al. Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I). Lancet 2010. https://europepmc.org/article/MED/20673995
5. Pi-Sunyer X et al. Psychiatric adverse events and effects on mood with prolonged-release naltrexone/bupropion: a pooled analysis. Int J Obes 2019. https://europepmc.org/article/MED/30664661